Compare HELP & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELP | ASPN |
|---|---|---|
| Founded | N/A | 2001 |
| Country | Canada | United States |
| Employees | 50 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.0M | 275.8M |
| IPO Year | N/A | 2011 |
| Metric | HELP | ASPN |
|---|---|---|
| Price | $5.65 | $3.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $51.50 | $4.25 |
| AVG Volume (30 Days) | 688.4K | ★ 1.2M |
| Earning Date | 07-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $271,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $50.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.29 | $2.30 |
| 52 Week High | $8.55 | $9.78 |
| Indicator | HELP | ASPN |
|---|---|---|
| Relative Strength Index (RSI) | 57.24 | 53.19 |
| Support Level | $4.40 | $2.95 |
| Resistance Level | $8.55 | $3.83 |
| Average True Range (ATR) | 0.30 | 0.31 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 79.09 | 44.08 |
Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.